Literature DB >> 33643865

Structural and Functional Consequences of Hypercortisolism on Brain: Are the Brain and Psycho-neuro-cognitive Manifestations Reversible?

Mahendra Kumar Garg1, Madhukar Mittal2.   

Abstract

Entities:  

Year:  2021        PMID: 33643865      PMCID: PMC7906096          DOI: 10.4103/ijem.IJEM_542_20

Source DB:  PubMed          Journal:  Indian J Endocrinol Metab        ISSN: 2230-9500


× No keyword cloud information.
  18 in total

1.  Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing's disease.

Authors:  M N Starkman; B Giordani; S S Gebarski; S Berent; M A Schork; D E Schteingart
Journal:  Biol Psychiatry       Date:  1999-12-15       Impact factor: 13.382

2.  Clinical correlates of major depression in Cushing's disease.

Authors:  N Sonino; G A Fava; A R Raffi; M Boscaro; F Fallo
Journal:  Psychopathology       Date:  1998 Nov-Dec       Impact factor: 1.944

3.  Overall and Disease-Specific Mortality in Patients With Cushing Disease: A Swedish Nationwide Study.

Authors:  Oskar Ragnarsson; Daniel S Olsson; Eleni Papakokkinou; Dimitrios Chantzichristos; Per Dahlqvist; Elin Segerstedt; Tommy Olsson; Maria Petersson; Katarina Berinder; Sophie Bensing; Charlotte Höybye; Britt Edén-Engström; Pia Burman; Lorenza Bonelli; Cecilia Follin; David Petranek; Eva Marie Erfurth; Jeanette Wahlberg; Bertil Ekman; Anna-Karin Åkerman; Erik Schwarcz; Ing-Liss Bryngelsson; Gudmundur Johannsson
Journal:  J Clin Endocrinol Metab       Date:  2019-06-01       Impact factor: 5.958

4.  Brain metabolite abnormalities in ventromedial prefrontal cortex are related to duration of hypercortisolism and anxiety in patients with Cushing's syndrome.

Authors:  Iris Crespo; Alicia Santos; Beatriz Gómez-Ansón; Olga López-Mourelo; Patricia Pires; Yolanda Vives-Gilabert; Susan M Webb; Eugenia Resmini
Journal:  Endocrine       Date:  2016-04-21       Impact factor: 3.633

5.  The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolism.

Authors:  L D Dorn; E S Burgess; T C Friedman; B Dubbert; P W Gold; G P Chrousos
Journal:  J Clin Endocrinol Metab       Date:  1997-03       Impact factor: 5.958

6.  Hippocampal Volume, Cognitive Functions, Depression, Anxiety, and Quality of Life in Patients With Cushing Syndrome.

Authors:  Katrine Emilie Frimodt-Møller; Jens Richardt Møllegaard Jepsen; Ulla Feldt-Rasmussen; Jesper Krogh
Journal:  J Clin Endocrinol Metab       Date:  2019-10-01       Impact factor: 5.958

7.  Neuropsychological deficits in Cushing's syndrome.

Authors:  T B Whelan; D E Schteingart; M N Starkman; A Smith
Journal:  J Nerv Ment Dis       Date:  1980-12       Impact factor: 2.254

8.  Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome.

Authors:  M N Starkman; S S Gebarski; S Berent; D E Schteingart
Journal:  Biol Psychiatry       Date:  1992-11-01       Impact factor: 13.382

9.  Long-term cognitive effects of glucocorticoid excess in Cushing's syndrome.

Authors:  Hélène Forget; André Lacroix; Isabelle Bourdeau; Henri Cohen
Journal:  Psychoneuroendocrinology       Date:  2015-11-30       Impact factor: 4.905

10.  Detrimental effects of hypercortisolism on brain structure and related risk factors.

Authors:  Yaxi Chen; Junhuai Zhang; Huiwen Tan; Jiaqi Li; Yerong Yu
Journal:  Sci Rep       Date:  2020-07-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.